A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis.

A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis. Ferroptosis is characterized ...

To identify these new molecules, a team of researchers led by Dr. Eikan Mishima and Dr. Marcus Conrad, both from the Institute of Metabolism and Cell Death at Helmholtz Munich, along with ...

The team was led by Dr. Eikan Mishima, Senior Scientist at the Institute of Metabolism and Cell Death at Helmholtz Munich and Tohoku University Graduate School of Medicine, and Professor Marcus ...

Marcus Conrad further comments “that inhibiting FSP1 with in vivo available FSP1-specific compounds could be a new effective anticancer strategy for the treatment of certain cancers". Reference: ...

This novel function of Vitamin K was discovered by a research team led by Dr. Eikan Mishima and Dr. Marcus Conrad, both from the Institute of Metabolism and Cell Death at Helmholtz Munich.